Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104193792B reveals a one-step microwave-assisted conversion of chenodeoxycholic acid. This report analyzes cost reduction in API manufacturing and supply chain reliability for high-purity ursodeoxycholic acid.
Discover the advanced asymmetric hydrogenation process for levo-nicotine. Achieve 99.7% optical purity with scalable, cost-effective pharmaceutical intermediate manufacturing.
Patent CN118598746A details asymmetric synthesis for high-purity intermediates. Enhance supply chain reliability and reduce manufacturing costs with scalable routes.
Novel immobilized transition metal complexes enable efficient asymmetric hydrogenation of ketoesters, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN108976178A reveals a safe, atmospheric Pd-catalyzed route for chiral sulfonamides. Discover cost-effective manufacturing and supply chain advantages.
Patent CN108383786A details asymmetric hydrogenation for dextromethorphan intermediates. Achieves high yield and purity with reduced costs for reliable pharmaceutical supply chains.
Patent CN106365949A reveals a breakthrough in chiral spiroindane synthesis, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN105294401A reveals high-ee synthesis route. Reduces catalyst cost significantly. Reliable supplier for pharmaceutical intermediates ensuring supply chain continuity.
Patent CN113845478A details a scalable total synthesis of oxycodone using asymmetric hydrogenation and Heck coupling, offering a reliable alternative to poppy extraction for pharmaceutical intermediates.
Patent CN106946823B reveals a novel catalytic route for high-purity (R)-jasmine lactone. This method reduces synthetic steps and improves optical purity for the flavor industry.
Novel mixed-solvent synthesis for high-purity chiral diamine ruthenium catalysts. Reduces recrystallization needs and boosts yield for asymmetric catalysis applications.
Novel Rh-catalyzed route for high-purity gamma-butyrolactone derivatives with superior enantioselectivity and scalable manufacturing capabilities for global pharma supply chains.
Patent CN111574487A details asymmetric hydrogenation for chiral dihydroisoflavones. Offers high enantioselectivity and scalable routes for pharmaceutical intermediates.
Discover a highly stereospecific process for paroxetine intermediates using chiral Ru-BINAP catalysts. Achieve superior purity and cost efficiency in API manufacturing.
Advanced preparation of tertiary alpha-aryl cyclic ketones via Pd-catalyzed coupling and enzymatic reduction. High purity pharmaceutical intermediates with scalable chemo-enzymatic technology.
Patent CN102803271B enables high-purity chiral halogenated alkanes via iridium-catalyzed hydrogenation, offering significant supply chain and cost advantages for pharmaceutical intermediate manufacturing.
Patent CN120020113A reveals a novel iridium-catalyzed method for high-purity chiral amines, offering significant cost reduction and supply chain reliability for agrochemical and pharmaceutical intermediates.
Novel catalytic transfer hydrogenation method for Ticagrelor intermediate. Reduces cost and toxicity compared to borane reduction. High ee value.
Patent CN1468852A reveals a breakthrough iridium-catalyzed method for asymmetric hydrogenation of aromatic heterocycles, offering high ee and scalable manufacturing for API intermediates.
Patent CN109574797A details water-based reduction for luliconazole intermediate. Offers high yield and purity with recyclable catalysts for cost-effective pharmaceutical manufacturing supply chains.